ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,000 | +127.3% | 35,818 | +144.9% | 0.00% | – |
| Q2 2020 | $11,000 | -62.1% | 14,627 | +42.6% | 0.00% | – |
| Q3 2019 | $29,000 | -73.1% | 10,260 | -27.4% | 0.00% | – |
| Q2 2019 | $108,000 | -20.0% | 14,124 | +39.0% | 0.00% | -100.0% |
| Q1 2019 | $135,000 | -22.0% | 10,163 | -8.7% | 0.00% | 0.0% |
| Q4 2018 | $173,000 | -31.1% | 11,131 | -12.9% | 0.00% | 0.0% |
| Q3 2018 | $251,000 | -38.2% | 12,773 | -9.6% | 0.00% | -50.0% |
| Q2 2018 | $406,000 | +9.1% | 14,137 | -10.0% | 0.00% | 0.0% |
| Q1 2018 | $372,000 | +30.5% | 15,709 | +18.1% | 0.00% | +100.0% |
| Q4 2017 | $285,000 | -12.3% | 13,306 | -3.3% | 0.00% | -50.0% |
| Q3 2017 | $325,000 | +27.0% | 13,761 | +6.1% | 0.00% | 0.0% |
| Q2 2017 | $256,000 | -3.4% | 12,972 | +2.7% | 0.00% | 0.0% |
| Q1 2017 | $265,000 | +1.1% | 12,629 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $262,000 | +6.5% | 12,566 | +35.3% | 0.00% | 0.0% |
| Q1 2016 | $246,000 | -50.3% | 9,286 | -19.8% | 0.00% | -60.0% |
| Q4 2015 | $495,000 | +124.0% | 11,576 | +38.6% | 0.01% | +150.0% |
| Q3 2015 | $221,000 | -12.3% | 8,351 | +10.3% | 0.00% | -33.3% |
| Q2 2015 | $252,000 | -3.4% | 7,570 | +18.7% | 0.00% | 0.0% |
| Q4 2014 | $261,000 | – | 6,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|